olivLaw · European equity research
Björn Borg AB BORG.ST
Sweden · Nasdaq Stockholm · ISIN SE0021921327 · Vertical: Listed companies from Sweden
At the close of 30 Oct 2026, Björn Borg AB (BORG.ST) stock was 58.80 SEK (+1.20% on the day), with market capitalisation 1.5 bn SEK, P/E 16.1 on diluted EPS of 3.66 SEK over the last 12 months, beta 0.49, 52-week range 53.20–76.00 SEK.
Data as of · Source: ESEF annual reports and closing prices, computed by olivLaw.
Price history
Loading chart…
Technical reading
- RSI (14)
- 65.6
- strong (55–70)
- Bollinger (20, 2)
- 51.47 – 58.07
- above the upper band · %B 1.11 · band width 12.1%
- SMA 50 / 200
- 55.96 / 62.63
- mixed trend
- MACD (12, 26, 9)
- 0.45 / -0.17
- MACD above signal
Indicators describe past prices; on their own they do not predict direction. On our history the RSI ≤ 40 filter added no return (see the signals methodology).
Performance
| Company | EURO STOXX 50 | vs EURO STOXX 50 | Vertical median | |
|---|---|---|---|---|
| 1 month | +7.9% | −2.2% | +10.1 pp | — |
| 3 months | −9.4% | −3.6% | −5.8 pp | — |
| 6 months | −12.5% | +4.2% | −16.7 pp | — |
| Year to date | −6.4% | +5.8% | −12.2 pp | — |
| 1 year | −7.4% | +7.6% | −15.0 pp | −0.4% |
| 3 years | +49.2% | +51.0% | −1.7 pp | +23.6% |
| 5 years | +55.4% | +44.2% | +11.1 pp | — |
Price returns, dividends excluded.
Quarterly results
ESEF annual reports carry no quarters: the results are annual (below).
E/P over time
E/P = trailing-12-month diluted EPS / price at quarter end. E/P is the inverse of P/E and stays defined when earnings are negative.
Today's P/E sits at the 33 percentile of its own 3-quarter history (min 14.8, median 17.2, max 17.9; quarters with earnings only).
Fiscal years
| Fiscal year | 2023 | 2024 | 2025 |
|---|---|---|---|
| Revenue | 891.8 m | 1.0 bn | 1.1 bn |
| Revenue YoY | unavailable | +13.6% | +5.8% |
| Net income | 76.0 m | 72.7 m | 92.1 m |
| Net income YoY | unavailable | −4.3% | +26.7% |
| Diluted EPS | 3.02 | 2.89 | 3.66 |
| Diluted EPS YoY | unavailable | −4.3% | +26.6% |
| net % | 8.5% | 7.2% | 8.6% |
| Free cash flow | 112.2 m | 64.6 m | 45.1 m |
Balance sheet & financial health
Fiscal year 2025 · 31 Dec 2025
- Cash
- 13.5 m SEK
- Financial debt
- unavailable SEK
- Net debt
- unavailable SEK
- Equity
- 361.0 m SEK
- Total assets
- 719.2 m SEK
- Debt / equity
- unavailable
- Current ratio
- 1.41x
- ROE
- 25.8%
- ROA
- 12.9%
- FCF margin
- 4.2%
Financial statements (source on every figure)
Revenue and net income (SEK)
Margins
Income statement · SEK
| Line | 2023 | 2024 | 2025 | Source (latest year) |
|---|---|---|---|---|
| Revenue | 891.8 m | 1.0 bn | 1.1 bn | esef· 28 Oct 2026verified |
| Operating income | 100.6 m | 101.8 m | 111.5 m | esef· 28 Oct 2026verified |
| Depreciation & amortisation | 33.0 m | 32.1 m | 29.1 m | esef· 28 Oct 2026verified |
| EBITDA | 133.6 m ≈ | 134.0 m ≈ | 140.6 m ≈ | esef· 28 Oct 2026derived |
| Interest expense | 6.1 m | 11.9 m | 7.0 m | esef· 28 Oct 2026verified |
| Pre-tax income | 97.7 m | 90.4 m | 117.7 m | esef· 28 Oct 2026verified |
| Income tax | 21.7 m | 17.7 m | 25.7 m | esef· 28 Oct 2026verified |
| Net income | 76.0 m | 72.7 m | 92.1 m | esef· 28 Oct 2026verified |
| Diluted EPS | 3.02 | 2.89 | 3.66 | esef· 28 Oct 2026verified |
≈ computed by olivLaw from the reported lines of the same year: Operating income + Depreciation & amortisation.
Balance sheet · SEK
| Line | 2023 | 2024 | 2025 | Source (latest year) |
|---|---|---|---|---|
| Cash | 26.6 m | 8.8 m | 13.5 m | esef· 28 Oct 2026verified |
| Receivables | 116.2 m | 133.9 m | 157.1 m | esef· 28 Oct 2026verified |
| Inventories | 184.4 m | 259.5 m | 257.2 m | esef· 28 Oct 2026verified |
| Current assets | 327.3 m | 402.2 m | 427.9 m | esef· 28 Oct 2026verified |
| Property, plant & equipment, net | 17.7 m | 63.3 m | 52.8 m | esef· 28 Oct 2026verified |
| Goodwill | 36.4 m | 37.2 m | 35.9 m | esef· 28 Oct 2026verified |
| Total assets | 631.5 m | 708.9 m | 719.2 m | esef· 28 Oct 2026verified |
| Current liabilities | 215.5 m | 294.4 m | 303.7 m | esef· 28 Oct 2026verified |
| Total liabilities | 280.7 m | 356.4 m | 358.2 m | esef· 28 Oct 2026verified |
| Equity | 350.8 m | 352.5 m | 361.0 m | esef· 28 Oct 2026verified |
| Shares outstanding at year end | 25.2 m | 25.1 m | 25.2 m | esef· 28 Oct 2026derived |
Cash flow · SEK
| Line | 2023 | 2024 | 2025 | Source (latest year) |
|---|---|---|---|---|
| Operating cash flow | 121.3 m | 76.0 m | 55.3 m | esef· 28 Oct 2026verified |
| Capex | 9.0 m | 11.4 m | 10.2 m | esef· 28 Oct 2026verified |
| Free cash flow | 112.2 m ≈ | 64.6 m ≈ | 45.1 m ≈ | esef· 28 Oct 2026derived |
| Investing cash flow | -11.1 m | -14.1 m | -12.4 m | esef· 28 Oct 2026verified |
| Financing cash flow | -101.6 m | -77.9 m | -47.3 m | esef· 28 Oct 2026verified |
≈ computed by olivLaw from the reported lines of the same year: Operating cash flow − Capex.
Computed indicators
Growth
Profitability
Returns
Balance sheet
Liquidity
Cash
Efficiency
Market and valuation
1 indicators that do not apply to the sector.
Valuation
olivLaw classification
- score weight coverage: 41.7% of at least 60%
A scoring methodology on indicators and valuation, not investment advice.
Closing price
30 Oct 2026Source: olivLaw, closing series
Market cap: 1.5 bn SEK
Key indicators
Coverage and freshness
Score by group
42% · Insufficient data
Estimated value range
unavailable — no valuation assumptions for the reporting currency
Valuation assumptions are editorial choices, not measured; beta is not measured.
Valuation methods
Assumptions (illustrative, editorial)
- Risk-free rate
- 6.5%
- Equity risk premium
- 6.0%
- Beta (default)
- 1.00
- Cost of equity
- 12.5%
- Terminal growth
- 3.0%
Factor scorecard
Insufficient data
Minimum-evidence gate: score weight coverage: 41.7% of at least 60%
| Factor | Value | Score | Weight used |
|---|---|---|---|
| ROIC · Quality | unavailable | unavailable | — |
| Net margin · Quality | 8.6% | 72 (vs peers) | 15% |
| FCF conversion · Quality | 49.0% | 27 (on a fixed band) | 15% |
| Revenue CAGR 3Y · Growth | unavailable | unavailable | — |
| EPS CAGR 3Y · Growth | unavailable | unavailable | — |
| Net debt / EBITDA · Balance sheet | unavailable | unavailable | — |
| Interest coverage · Balance sheet | 15.9x | 100 (on a fixed band) | 15% |
| Current ratio · Balance sheet | 1.4x | 51 (on a fixed band) | 10% |
| P/E (TTM) · Valuation | 16.1x | 76 (vs peers) | 25% |
| EV/EBITDA · Valuation | unavailable | unavailable | — |
| FCF yield · Valuation | 3.1% | 38 (on a fixed band) | 20% |
| Shareholder yield (distributions) · Returns | unavailable | unavailable | — |
| Payout ratio (FCF) · Returns | unavailable | unavailable | — |
Factors without a value were dropped; the remaining weights were renormalised.
Score groups
- Balance sheet80/100 · 2/3 factors with a value
- Growth· partialunavailable · 0/2 factors with a value
- Quality50/100 · 2/3 factors with a value
- Returns· partialunavailable · 0/2 factors with a value
- Valuation59/100 · 2/3 factors with a value
A «partial» group is computed from under half of its weight or from one factor: it is not a full assessment of the group.
Memo
Björn Borg AB (BORG.ST). Latest full fiscal year: 2025; data up to 2025-12-31.
Figures computed from the financial statements: revenue 1.1 bn SEK in 2025; YoY growth 5.8%; net margin 8.6%; ROE 25.4%.
The estimated value range is 58.23–117.95 SEK per share (median of 1 methods, agreement: single method); assumptions are illustrative. Against the central value of 86.60 SEK, the price of 58.80 SEK leaves a potential of 47.3% (value / price − 1) and a margin of safety of 32.1% (1 − price / value). The range is the median of the methods' low, central and high values, not a probability interval.
Insufficient data for a verdict (score weight coverage: 41.7% of at least 60%).
Text generated deterministically from the figures shown; no language model. Not investment advice.
What supports the thesis
- Net margin: 8.6%
- Interest coverage: 15.9x
- P/E (TTM): 16.1x
What contradicts it
- FCF conversion: 49.0%
Not assessed (insufficient data or a ratio without meaning): ROIC, Revenue CAGR 3Y, EPS CAGR 3Y, Net debt / EBITDA, EV/EBITDA, Shareholder yield (distributions), Payout ratio (FCF).
Versus the vertical median
Listed companies from Sweden · same country · compared with 39 companies
Multiples and returns vs the median
Price rebased to 100 (monthly, 5 years)
Companies in the vertical
| Market cap | P/E | ROE | Net margin | Revenue YoY | 1A / 3A | |
|---|---|---|---|---|---|---|
| ALFA.STAlfa Laval AB | 225.5 bn | 27.3 | 19.4% | 11.9% | +4.1% | +20% / +51% |
| BOL.STBoliden Ab | 140.8 bn | 15.0 | 13.3% | 10.1% | +4.8% | +17% / +75% |
| CAST.STCastellum Aktiebolag | 64.7 bn | 69.0 | 1.2% | 9.8% | −2.6% | +22% / +24% |
| AAK.STAak Ab (publ) | 45.9 bn | 13.4 | 17.2% | 7.5% | +2.2% | −33% / −17% |
| CAMX.STCamurus AB | 39.9 bn | 54.9 | 19.5% | 32.5% | +21.3% | +8% / +101% |
| BRAV.STBravida Holding AB | 31.7 bn | 25.8 | 13.7% | 4.4% | −4.9% | +92% / +122% |
| ASKER.STAsker Healthcare Group AB | 28.0 bn | 57.0 | 9.8% | 2.9% | +11.7% | −17% / unavailable |
| BURE.STBure Equity AB | 22.7 bn | — | -21.0% | — | unavailable | +10% / +38% |
| ALLEI.STAlleima AB | 22.4 bn | 33.3 | 4.1% | 3.6% | −5.4% | +9% / +32% |
| AQ.STAQ Group AB | 21.2 bn | 31.3 | 14.9% | 7.5% | +6.0% | +18% / +156% |
| ATT.STAttendo AB (publ) | 17.4 bn | 21.5 | 15.1% | 4.3% | +0.1% | +45% / +230% |
| ALTRA.STAltra Fastigheter AB | 17.3 bn | 31.9 | 3.0% | 15.1% | −2.2% | −4% / +45% |
| AFRY.STAfry Ab | 14.7 bn | 18.3 | 6.2% | 3.1% | −5.2% | −21% / +11% |
| ATRLJ-B.STAtrium Ljungberg AB | 13.4 bn | 16.2 | 2.9% | 23.9% | −2.0% | −38% / −38% |
| ALIG.STAlimak Group AB (publ) | 12.5 bn | 21.0 | 8.2% | 8.8% | −3.2% | −16% / +80% |
| ACAD.STAcadeMedia AB | 11.9 bn | 14.5 | 12.7% | 4.3% | +9.7% | +12% / +155% |
| BOOZT.STBoozt AB | 9.9 bn | 35.4 | 10.4% | 3.6% | +0.5% | +54% / +103% |
| APOTEA.STApotea AB (publ) | 9.6 bn | 41.9 | 31.3% | 3.2% | +10.1% | +11% / unavailable |
| BUFAB.STBufab AB (publ) | 5.1 bn | 9.2 | 15.1% | 6.9% | −7.4% | +28% / +153% |
| ACTI.STActive Biotech AB (publ) | 5.0 bn | — | -84.5% | — | unavailable | −35% / −80% |
| COOR.STCoor Service Management Holding AB | 4.7 bn | 18.2 | 13.0% | 2.2% | +16.7% | +5% / +28% |
| CEVI.STCellaVision AB | 4.7 bn | 30.5 | 18.0% | 20.2% | +4.9% | +9% / +44% |
| BHG.STBHG Group AB | 4.4 bn | 30.5 | 2.5% | 1.4% | +6.2% | −14% / +151% |
| CARA.STCarasent AB (publ) | 1.9 bn | 53.8 | 4.1% | 10.1% | +24.9% | −6% / +68% |
| BICO.STBICO Group AB | 1.7 bn | — | -46.0% | -72.7% | −13.3% | +14% / −17% |
1- and 3-year price returns: for BORG.ST from daily closes (the same as the performance table), for the other companies from month-end closes.
olivLaw engine forecast
The world engine ran after the company's latest material disclosure. Probabilities are of TOUCHING a level within the horizon (not closing there) and sit next to the random walk (p_rw), the no-information benchmark.
The engine has no published run for this company yet.
Valuation scenarios (editable assumptions)
Illustrative scenarios
Illustrative: not forecasts and without probabilities. Each case is one coherent set of assumptions, computed on today's figures.
Estimated price (SEK)
| Estimated price | Bear | Base | Bull |
|---|---|---|---|
| 1 years | 35.22 Total return -40% · Per year -40% | 62.22 Total return 6% · Per year 6% | 93.67 Total return 59% · Per year 59% |
| 3 years | 35.09 Total return -40% · Per year -16% | 69.68 Total return 19% · Per year 6% | 115.04 Total return 96% · Per year 25% |
| 5 years | 34.97 Total return -41% · Per year -10% | 78.03 Total return 33% · Per year 6% | 141.29 Total return 140% · Per year 19% |
- Exit P/E± 17.42
- Net margin± 12.19
- Annual revenue growth± 9.88
- Annual dilution± 1.02
AI analysis
The qualitative analysis has not been written for this company yet.
Products, market & competition
The qualitative analysis has not been written for this company yet.
News & filings
In the press
No news in our archive over the last 180 days.
Annual reports (ESEF)
- Annual report 202528 Oct 2026
- Annual report 202408 May 2025
Figures computed by olivLaw from ESEF annual reports and closing prices; the qualitative analysis is AI-generated from cited sources. Not investment advice.